A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART. (Q40919787)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART. |
scientific article |
Statements
A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART (English)
Christian Brander
José Luis Jiménez
Beatriz Perdiguero
Victoria Cepeda
Juan Carlos López Bernaldo de Quirós
Carlos Óscar Sánchez-Sorzano
6 November 2015
6 November 2015
1 reference
1 reference
1 reference
1 reference